Bisphosphonate Treatment for Children With Disabling Conditions
PM and R
Fractures are a frequent source of morbidity in children with disabling conditions. The assessment of bone density in this population is challenging, because densitometry is influenced by dynamic forces affecting the growing skeleton and may be further confounded by positioning difficulties and surgical hardware. First-line treatment for pediatric osteoporosis involves conservative measures, including optimizing the management of underlying conditions, maintaining appropriate calcium and vitamin D intake, encouraging weight-bearing physical activity, and monitoring measurements of bone mineral density. Bisphosphonates are a class of medications that increase bone mineral density by inhibiting bone resorption. Although bisphosphonates are commonly prescribed for treatment of adult osteoporosis, their use in pediatric patients is controversial because of the lack of long-term safety and efficacy data. © 2014 American Academy of Physical Medicine and Rehabilitation.
Boyce, A., Tosi, L., & Paul, S. (2014). Bisphosphonate Treatment for Children With Disabling Conditions. PM and R, 6 (5). http://dx.doi.org/10.1016/j.pmrj.2013.10.009